NCT05972772View on ClinicalTrials.gov

Rickettsia Clearance Study

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2026

Conditions
Infectious DiseaseTherapeutics
Interventions
DRUG

Doxycyclin

100-mg film-coated tablets; Pfizer

DRUG

Azithromycin

250-mg capsules; Pfizer

Trial Locations (2)

0103

RECRUITING

Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Vientiane

Unknown

RECRUITING

Vientiane Provincial Hospital, Vientiane Province

All Listed Sponsors
collaborator

Mahidol Oxford Tropical Medicine Research Unit

OTHER

lead

Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit

OTHER